↓ Skip to main content

Survival with AGS-003, an autologous dendritic cell–based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
10 tweeters

Citations

dimensions_citation
122 Dimensions

Readers on

mendeley
104 Mendeley